The cardiac GHS-R1a biology of ipamorelin and related GH secretagogues (ghrelin, hexarelin, GHRP-6) is a well-established preclinical research field with relevance to myocardial infarction, heart failure, cardiomyopathy, and cardiac ageing
[4], from a large survey we conducted on over 1100 PA patients shows that 40% of PA patients wait two years or longer for diagnosis, further complicating patient outcomes and satisfaction (Thain et al., 2024, DOI: 10.1101/2024.08.30.24312837)
doi: 10.1016/S0140-6736(20)32511-3 Summary Keywords chronic liver disorder, metabolic syndrome, non-alcoholic fatty liver disease, oxidative stress, oral glutathione Citation Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV and Di Sabatino A (2023) Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
A 2025 Nature Communications paper mapped the binding to the disordered transactivation domain of p53, adding structural detail to how FOXO4-DRI engages its target
& Varshney, A
Now, while glutathione is commonly used to lighten the skin, some users report experiencing glutathione skin darkening, which can happen due to individual skin responses